奥曲肽联合前列地尔治疗急性胰腺炎临床效果观察
 |
| 第1页 |
参见附件。
摘 要：目的 ：探讨奥曲肽联合前列地尔治疗急性胰腺炎(AP)临床疗效。方法： 选取我院2013年1月-2014年6月收治的急性胰腺炎患者59例，随机分为两组，对照组29例，观察组30例，对照组患者采用奥曲肽治疗，观察组患者联合应用奥曲肽和前列地尔，观察比较两组患者治疗的的临床疗效和并发症发生情况。结果： 观察组治疗1周后总有效率达93.3%(28/30)，对照组总有效率为72.4%(21/29)，差异显著(P<0.05);观察组并发症发生率为6.7%(2/30),明显低于对照组的20.7%(6/29)，差异有统计学意义(P<0.05)。结论： 联用奥曲肽和前列地尔治疗急性胰腺炎具有显著的疗效，能有效改善患者的生命体征和临床症状，减少并发症的发生，值得在临床上进一步推广。
关键词：奥曲肽；前列地尔；急性胰腺炎
Abstract： Objective To evaluate the clinical efficacy of octreotide alprostadil treatment of acute pancreatitis (AP). Methods 59 cases of acute pancreatitis in our hospital patients in January 2013 -2014 in June admitted, were randomly divided into two groups, a control group of 29 patients, 30 patients in the control group of patients in the observation group using octreotide treatment, the observation group were combined octreotide and alprostadil, the two groups were observed and compared the clinical efficacy of treatment and complications were observed ......
您现在查看是摘要介绍页，详见PDF附件。